CLINICAL_TRIALS
trial_result
· 2024-06-03
Clinical Trial Update: Impact of Evolocumab in Cardiac Transplant Patients With CAV [Phase 2]
Summary
A Phase 2 trial evaluating evolocumab in heart transplant recipients with cardiac allograft vasculopathy has posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Nebraska | Conditions: Heart Transplant | Phase 2 | Status: COMPLETED | Results posted: 2024-06-03